Trends in Use of Next-Generation Sequencing in Patients With Solid Tumors by Race and Ethnicity After Implementation of the Medicare National Coverage Determination.

ABSTRACT:

Importance

In March 2018, Medicare issued a national coverage determination (NCD) for next-generation sequencing (NGS) to facilitate access to NGS testing among Medicare beneficiaries. It is unknown whether the NCD affected health equity issues for Medicare beneficiaries and the overall population.

Objective

To examine the association between the Medicare NCD and NGS use by insurance types and race and ethnicity.

Design, setting, and participants

A retrospective cohort analysis was conducted using electronic health record data derived from a real-world database. Data originated from approximately 280 cancer clinics (approximately 800 sites of care) in the US. Patients with advanced non-small cell lung cancer (aNSCLC), metastatic colorectal cancer (mCRC), metastatic br

SUBMITTER: Sheinson DM 

PROVIDER: S-EPMC8662372 | biostudies-literature | 2021 Dec

REPOSITORIES: biostudies-literature